Literature DB >> 33893286

CRISPR-Cas9 cytidine and adenosine base editing of splice-sites mediates highly-efficient disruption of proteins in primary and immortalized cells.

Mitchell G Kluesner1,2,3,4, Walker S Lahr1,2,3,4, Cara-Lin Lonetree1,2,3,4, Branden A Smeester1,2,3,4, Xiaohong Qiu1,2,3,4, Nicholas J Slipek1,2,3,4, Patricia N Claudio Vázquez1,2,3,4,5, Samuel P Pitzen2,5, Emily J Pomeroy1,2,3,4, Madison J Vignes6, Samantha C Lee5,6, Samuel P Bingea1,2,3,4, Aneesha A Andrew5,6, Beau R Webber7,8,9,10, Branden S Moriarity11,12,13,14.   

Abstract

CRISPR-Cas9 cytidine and adenosine base editors (CBEs and ABEs) can disrupt genes without introducing double-stranded breaks by inactivating splice sites (BE-splice) or by introducing premature stop (pmSTOP) codons. However, no in-depth comparison of these methods or a modular tool for designing BE-splice sgRNAs exists. To address these needs, we develop SpliceR ( http://z.umn.edu/spliceR ) to design and rank BE-splice sgRNAs for any Ensembl annotated genome, and compared disruption approaches in T cells using a screen against the TCR-CD3 MHC Class I immune synapse. Among the targeted genes, we find that targeting splice-donors is the most reliable disruption method, followed by targeting splice-acceptors, and introducing pmSTOPs. Further, the CBE BE4 is more effective for disruption than the ABE ABE7.10, however this disparity is eliminated by employing ABE8e. Collectively, we demonstrate a robust method for gene disruption, accompanied by a modular design tool that is of use to basic and translational researchers alike.

Entities:  

Year:  2021        PMID: 33893286     DOI: 10.1038/s41467-021-22009-2

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  57 in total

1.  Genome engineering using the CRISPR-Cas9 system.

Authors:  F Ann Ran; Patrick D Hsu; Jason Wright; Vineeta Agarwala; David A Scott; Feng Zhang
Journal:  Nat Protoc       Date:  2013-10-24       Impact factor: 13.491

2.  A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.

Authors:  Martin Jinek; Krzysztof Chylinski; Ines Fonfara; Michael Hauer; Jennifer A Doudna; Emmanuelle Charpentier
Journal:  Science       Date:  2012-06-28       Impact factor: 47.728

3.  Multiplex genome engineering using CRISPR/Cas systems.

Authors:  Le Cong; F Ann Ran; David Cox; Shuailiang Lin; Robert Barretto; Naomi Habib; Patrick D Hsu; Xuebing Wu; Wenyan Jiang; Luciano A Marraffini; Feng Zhang
Journal:  Science       Date:  2013-01-03       Impact factor: 47.728

4.  RNA-guided human genome engineering via Cas9.

Authors:  Prashant Mali; Luhan Yang; Kevin M Esvelt; John Aach; Marc Guell; James E DiCarlo; Julie E Norville; George M Church
Journal:  Science       Date:  2013-01-03       Impact factor: 47.728

5.  Repair of double-strand breaks induced by CRISPR-Cas9 leads to large deletions and complex rearrangements.

Authors:  Michael Kosicki; Kärt Tomberg; Allan Bradley
Journal:  Nat Biotechnol       Date:  2018-07-16       Impact factor: 54.908

6.  CRISPR-engineered T cells in patients with refractory cancer.

Authors:  Edward A Stadtmauer; Joseph A Fraietta; Simon F Lacey; Carl H June; Megan M Davis; Adam D Cohen; Kristy L Weber; Eric Lancaster; Patricia A Mangan; Irina Kulikovskaya; Minnal Gupta; Fang Chen; Lifeng Tian; Vanessa E Gonzalez; Jun Xu; In-Young Jung; J Joseph Melenhorst; Gabriela Plesa; Joanne Shea; Tina Matlawski; Amanda Cervini; Avery L Gaymon; Stephanie Desjardins; Anne Lamontagne; January Salas-Mckee; Andrew Fesnak; Donald L Siegel; Bruce L Levine; Julie K Jadlowsky; Regina M Young; Anne Chew; Wei-Ting Hwang; Elizabeth O Hexner; Beatriz M Carreno; Christopher L Nobles; Frederic D Bushman; Kevin R Parker; Yanyan Qi; Ansuman T Satpathy; Howard Y Chang; Yangbing Zhao
Journal:  Science       Date:  2020-02-06       Impact factor: 47.728

Review 7.  Unleashing the Therapeutic Potential of CAR-T Cell Therapy Using Gene-Editing Technologies.

Authors:  In-Young Jung; Jungmin Lee
Journal:  Mol Cells       Date:  2018-08-14       Impact factor: 5.034

8.  CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations.

Authors:  Grégoire Cullot; Julian Boutin; Jérôme Toutain; Florence Prat; Perrine Pennamen; Caroline Rooryck; Martin Teichmann; Emilie Rousseau; Isabelle Lamrissi-Garcia; Véronique Guyonnet-Duperat; Alice Bibeyran; Magalie Lalanne; Valérie Prouzet-Mauléon; Béatrice Turcq; Cécile Ged; Jean-Marc Blouin; Emmanuel Richard; Sandrine Dabernat; François Moreau-Gaudry; Aurélie Bedel
Journal:  Nat Commun       Date:  2019-03-08       Impact factor: 14.919

9.  RNA-programmed genome editing in human cells.

Authors:  Martin Jinek; Alexandra East; Aaron Cheng; Steven Lin; Enbo Ma; Jennifer Doudna
Journal:  Elife       Date:  2013-01-29       Impact factor: 8.140

Review 10.  The CRISPR tool kit for genome editing and beyond.

Authors:  Mazhar Adli
Journal:  Nat Commun       Date:  2018-05-15       Impact factor: 14.919

View more
  12 in total

Review 1.  Improvement of base editors and prime editors advances precision genome engineering in plants.

Authors:  Kai Hua; Peijin Han; Jian-Kang Zhu
Journal:  Plant Physiol       Date:  2022-03-28       Impact factor: 8.340

2.  Efficient in vivo base editing via single adeno-associated viruses with size-optimized genomes encoding compact adenine base editors.

Authors:  Jessie R Davis; Xiao Wang; Isaac P Witte; Tony P Huang; Jonathan M Levy; Aditya Raguram; Samagya Banskota; Nabil G Seidah; Kiran Musunuru; David R Liu
Journal:  Nat Biomed Eng       Date:  2022-07-28       Impact factor: 29.234

Review 3.  Developing Bottom-Up Induced Pluripotent Stem Cell Derived Solid Tumor Models Using Precision Genome Editing Technologies.

Authors:  Kelsie L Becklin; Garrett M Draper; Rebecca A Madden; Mitchell G Kluesner; Tomoyuki Koga; Miller Huang; William A Weiss; Logan G Spector; David A Largaespada; Branden S Moriarity; Beau R Webber
Journal:  CRISPR J       Date:  2022-08

Review 4.  CRISPR-based genome editing through the lens of DNA repair.

Authors:  Tarun S Nambiar; Lou Baudrier; Pierre Billon; Alberto Ciccia
Journal:  Mol Cell       Date:  2022-01-20       Impact factor: 17.970

Review 5.  CRISPR/Cas9 ribonucleoprotein-mediated genome and epigenome editing in mammalian cells.

Authors:  Hanan Bloomer; Jennifer Khirallah; Yamin Li; Qiaobing Xu
Journal:  Adv Drug Deliv Rev       Date:  2021-12-20       Impact factor: 15.470

Review 6.  CRISPR/Cas9: Principle, Applications, and Delivery through Extracellular Vesicles.

Authors:  Katarzyna Horodecka; Markus Düchler
Journal:  Int J Mol Sci       Date:  2021-06-04       Impact factor: 5.923

7.  mRNA-mediated delivery of gene editing tools to human primary muscle stem cells.

Authors:  Christian Stadelmann; Silvia Di Francescantonio; Andreas Marg; Stefanie Müthel; Simone Spuler; Helena Escobar
Journal:  Mol Ther Nucleic Acids       Date:  2022-02-28       Impact factor: 8.886

8.  Base Editors for Citrus Gene Editing.

Authors:  Xiaoen Huang; Yuanchun Wang; Nian Wang
Journal:  Front Genome Ed       Date:  2022-02-28

Review 9.  The use of base editing technology to characterize single nucleotide variants.

Authors:  Sophia McDaniel; Alexis Komor; Alon Goren
Journal:  Comput Struct Biotechnol J       Date:  2022-03-31       Impact factor: 6.155

10.  Robust genome editing via modRNA-based Cas9 or base editor in human pluripotent stem cells.

Authors:  Tahir Haideri; Alessandro Howells; Yuqian Jiang; Jian Yang; Xiaoping Bao; Xiaojun Lance Lian
Journal:  Cell Rep Methods       Date:  2022-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.